reproductive toxicity of cyto reproductive toxicity of
play

Reproductive toxicity of cyto Reproductive toxicity of cyto-static - PowerPoint PPT Presentation

Reproductive toxicity of cyto Reproductive toxicity of cyto-static static drugs and pharmacological ways to drugs and pharmacological ways to reduce it reduce it Laboratory of Pharmacology of Reproductive System The Goldberg Research


  1. Reproductive toxicity of cyto Reproductive toxicity of cyto-static static drugs and pharmacological ways to drugs and pharmacological ways to reduce it reduce it Laboratory of Pharmacology of Reproductive System The Goldberg Research Institute of Pharmacology, Tomsk, RUSSIA by Tatyana Borovskaya

  2. Intensity of reproductive dysfunction in women with cancer under different treatment regimens Status of reproductive Disease Scheme function �� F Breast Cancer amenorrhea in 88% FAC amenorrhea in 55% amenorrhea amenorrhea Hemoblastosis Hemoblastosis COPP COPP amenorrhea in the majority of EEACOPP amenorrhea women CHOP Violations in ovarian cycle are ABVD minimal Does not result in sterilization Ovarian cancer POMB/ACE (after conserving surgery)

  3. � Berthon L. (1987). Traitements anticancereux et fertilite. J. France Medicine, 94:247-8. � Mormor D. (1993). Fertile après traitements cytostatiques. Contracept.-fertil.-sex., 21(10):739-43. � Evain P.L. Bazonzelly M., Dusol F., Demaille M. (1986). Chemiotherapia anticancereuse at fertilite cher la femime. Rev. Fr. gynecolog at obsted. , 3:451-4. gynecolog at obsted. , 3:451-4. � Howell S.G., Shalet S.M. (2001). Testicular function following chemoterapy. Human Reprod. Update, 7 (4):3369-3. � Taksey Y, dissada N.K., Chayndhary U.B. (2003). Fertility after chemotherapy for testicular cancer. Arch. Androl ., 49(5):389-95.

  4. Group and name of the drug, Group and name of the drug, Main mechanism of anti Main mechanism of anti-tumor action tumor action chemical structure chemical structure PLATINUM COMPLEXES � isplatin, � isplatin, Lachema AC Lachema AC, , Austria Austria Form a cross-link between DNA molecules Form a cross link between DNA molecules Carboplatin, Carboplatin, EBEWE Pharma EBEWE Pharma, , Austria Austria ANTHRACYCLINE ANTIBIOTICS Doxorubicin, EBEWE Pharma Doxorubicin, Doxorubicin, EBEWE Pharma Doxorubicin, EBEWE Pharma, EBEWE Pharma, , Austria , Austria Austria Austria Intercalation between the base pairs of Intercalation between the base pairs of DNA DNA Epirubicin, Epirubicin, Karlo Arba Karlo Arba, Italy , Italy INHIBITORS TOPOIZOMERAZNOY ACTIVITY � toposide, � toposide, Teva Pharmaceutical Industries Teva Pharmaceutical Industries, , Inhibition of topoisomerase nhibition of topoisomerase II II Israel Israel TAXOIDS Stimulation of assembling of anomalous Stimulation of assembling of anomalous Paclitaxel, Paclitaxel, Dr Reddis Dr Reddis, I , India ndia microtubules microtubules

  5. The object of study is Wistar rats The drugs were administered intravenously in a single MTD, because in clinics high-dose therapy is used Methods of study • morphological (using quantitative indicators characterizing extent of the damage) gonads testes • functional • ( fertility index, the index pregnancy, fetal death) Research terms The assessment of effects was performed 3 and 6 months after administration of cyto-static drugs

  6. Early antiproliferative effects of cytotoxic drugs on gonads On ovarian tissue:: On testicular tissue: "DNA-comets" of mouse testis Death of follicular epithelium cells A B � � – cells with B – Apotopic DNA-damages "DNA-comets" Primordial follicles Tubules with the 12th stage Number of normal 1200 of meiosis, % spermatogonia, % of control 900 600 300 0 0 30 60 90 120 150 180 ����������������� ��������� ������������� ������������ ���������� Control

  7. Content of structural-functional elements of rats ovaries, 6 months after a single injection of anticancer drugs in the MTD (% of control) Ep Cs Cr Et P Ep Cs Cr Et P Ep Cs Cr Et P Primordial follicles Double or multiple follicles Graafian follicles Total number of generative elements Ep – Epirubicin; Cs – Cisplatin; Cr – Carboplatin; Et – Etoposide; P – Paclitaxel

  8. Intensity of long-term-late effects of cyto-static drugs on structural and functional elements of the rat ovary is decreased in the following order: ���������� ��������� ���������� ��������� �����������

  9. Efficiency of mating in female-rats in the long-term period after administration of cytotoxic drugs of different groups ��� �� �� �� �� Ep Cs Cr Et P � ��������������������� Ep – Epirubicin; Cs – Cisplatin; Cr – Carboplatin; Et – Etoposide; P – Paclitaxel

  10. Embryonic mortality in female rats while the crossbreeding long-term period after administration of cito-static drugs of different groups (% of control) ��� * �� * �� * * * * * �� �� Ep Cs Cr Et P Ep Cs Cr Et P � ������������������������� �������������������������� Ep – Epirubicin; Cs – Cisplatin; Cr – Carboplatin; Et – Etoposide; P – Paclitaxel

  11. Toxic effect of drugs on embryonic mortality is decreased in the following order: ������� ������������������� ������������������� ������������������ �������������� ���������� �����������

  12. Morphological status of the testes of rats at 3 months after administration of Paclitaxel and Epirubicin Testis rats 3 months after administration of Intact rat testis, age 5.5 months, x160. Paclitaxel and / or Epirubicin, x160. Staining with hematoxylin and eosin. Thinning seminiferous epithelium. Staining with hematoxylin and eosin.

  13. Sperm count, and efficiency of mating male rats at 3 months after administration of cyto-static drugs of different groups ��� � ��� �� * * �� �� �� �� Ep Cr Cs Et P Ep Cr Cs Et P � * � ����������������!�������� ��������������������!�"��� ������� Ep – Epirubicin; Cs – Cisplatin; Cr – Carboplatin; Et – Etoposide; P – Paclitaxel

  14. State of reproductive system of male rats long-term after administration of cyto-static drugs of different groups Level of Level of (DLM) (DLM) (characterizes the (characterizes the Drug Drug Sexual instinct exual instinct Fertility Fertility probability to save probability to save pregnancy) pregnancy) Platidiam Not disturbed Not disturbed Not increased � arboplatin Not disturbed Not disturbed Not increased Pharmorubicin Not disturbed Infertility, 100 % Not increased Doxorubicin Not disturbed Not disturbed Not increased Etoposide Not disturbed Not disturbed Increased Paclitaxel Infertility, 100 % Increased Not disturbed Toxicity decreases in the following order: Pharmorubicin Etoposide Paclitaxel In platinum drugs toxicity was not found

  15. Possible ways to reduce the long-term consequences of the effect of cyto-static drugs on reproductive system by assisting reproductive technologies � Testis tissue biopsy � Cryopreservation of sperm � Cryopreservation of oocytes IVF ISI � Cryopreservation of � Cryopreservation of ovarian tissue embryos � Differentiation of bone marrow stem cells into male germ cells Comments: IVF - in vitro fertilization ISI - Intracytoplasmic Sperm ��������� ������������������������������#�����$��������% Injection �& '��$����� ���� - human spermatogonial �& (����������������������������$�����������������$����$����� stem cell )& $��$��������#����������������������*���

  16. The effectiveness of drug therapy as the way to reduce the effects of cyto-static gonadotoxicity � Immunomodulators [ Carmely A., 2009 ] � Gonadal-hormone . products Drugs limiting apoptosis in oocytes � Hypothalamic � Stimulator of (sfignozin regulators spermatogenesis spermatogenesis monophosphate) monophosphate) of pituitary function of pituitary function (testosterone) [ Tilly J.L. et al., 2004 ] [ B � cker L. et al., 1990; +,,-./01234/5�206.78� Borovskaya � .G. et al., 2007 ] � Means of regenerative [ Delis J. et al., 1987 ] medicine [ Borovskya � .G., Dygai � . � ., ;�������������� Zhdanov V.V., 2008 ] ������!�$��$�� �������#� � Antioxidants 9�:� [ Kolomietz � .L. et al., 2001; ���������� Borovskaya � .G. et al., 2003 ] <�����#���������% �&'��$����� �&(����������������������������$������� ����������$����$�����

  17. Number of structural and functional elements of rats ovaries, 6 months after combined administration of Etoposide and Buserelin % of control (etoposide) Primordial Yellow Double and Atretic follicle Graafian follicles body multiple follicles follicles

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend